University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
JAMA Surg. 2014 Dec;149(12):1323-9. doi: 10.1001/jamasurg.2014.2440.
The clinical evidence base demonstrating bariatric surgery's health benefits is much larger than it was when the National Institutes of Health last held a consensus panel in 1991. Still, it remains unclear whether ongoing studies will address critical questions about long-term complication rates and the sustainability of weight loss and comorbidity control.
To summarize findings from a multidisciplinary workshop convened in May 2013 by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung, and Blood Institute. The workshop aimed to summarize the current state of knowledge of bariatric surgery, review research findings on the long-term outcomes of bariatric surgery, and establish priorities for future research directions.
The evidence presented at the workshop was selected by the planning committee for both its quality and duration of follow-up. The data review emphasized randomized clinical trials and large observational studies with long-term follow-up, with or without a control group.
Several small randomized clinical trials showed greater weight loss and type 2 diabetes mellitus remission compared with nonsurgical treatments within the first 2 years of follow-up after bariatric surgery. Large, long-term observational studies have shown durable (>5 years) weight loss, diabetes, and lipid improvements with bariatric surgery. Still unclear are predictors of outcomes, long-term complications, long-term survival, microvascular and macrovascular events, mental health outcomes, and costs. The studies needed to address these knowledge gaps would be expensive and logistically difficult to perform.
High-quality evidence shows that bariatric surgical procedures result in greater weight loss than nonsurgical treatments and are more effective at inducing initial type 2 diabetes mellitus remission in obese patients. More information is needed about the long-term durability of comorbidity control and complications after bariatric procedures and this evidence will most likely come from carefully designed observational studies.
与 1991 年美国国立卫生研究院(National Institutes of Health)举行共识小组会议时相比,目前已有大量临床证据表明减重手术对健康有益。不过,仍不清楚正在进行的研究是否会解决长期并发症发生率以及体重减轻和合并症控制的可持续性等关键问题。
总结 2013 年 5 月由美国国立糖尿病、消化和肾脏疾病研究所(National Institute of Diabetes and Digestive and Kidney Diseases)和美国国立心肺血液研究所(National Heart, Lung, and Blood Institute)召集的多学科研讨会的结果。该研讨会旨在总结减重手术的现有知识状况,回顾减重手术长期结果的研究结果,并确定未来研究方向的重点。
研讨会的规划委员会根据研究质量和随访时间选择了提交的证据。数据审查强调了随机临床试验和具有长期随访的大型观察性研究,无论是否有对照组。
几项小型随机临床试验显示,与减重手术前 2 年内的非手术治疗相比,减重手术后体重减轻和 2 型糖尿病缓解的效果更大。大型、长期的观察性研究表明,减重手术可实现持久(>5 年)的体重减轻、糖尿病和血脂改善。结局预测因素、长期并发症、长期生存、微血管和大血管事件、心理健康结局以及成本仍然不清楚。解决这些知识空白的研究需要花费大量的资金,并且在操作上也很困难。
高质量证据表明,减重手术程序可导致比非手术治疗更大的体重减轻,并且在诱导肥胖患者 2 型糖尿病初始缓解方面更为有效。关于减重手术后合并症控制和并发症的长期持久性,还需要更多信息,这些证据很可能来自精心设计的观察性研究。